These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22027724)

  • 1. From bench to Paccocath.
    Cremers B; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K23-31. PubMed ID: 22027724
    [No Abstract]   [Full Text] [Related]  

  • 2. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
    Speck U; Scheller B; Rutsch W; Laule M; Stangl V
    EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCI in small vessels: the case for a drug-coated balloon based intervention.
    Zeymer U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
    Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesions in small coronary vessels disease: should drug-coated balloons replace drug-eluting stents as the treatment of choice?
    Byrne RA; Kastrati A
    EuroIntervention; 2011 May; 7 Suppl K():K47-52. PubMed ID: 22027727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-stent restenosis: the gold standard has changed.
    Chin K
    EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New technologies in percutaneous coronary interventions: drug-coated balloons.
    Kleber FX; Scheller B; Serruys PW
    EuroIntervention; 2011 May; 7 Suppl K():K7. PubMed ID: 22027732
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted vascular drug delivery. A new day for an old way.
    Buchbinder M; Solar R
    Panminerva Med; 2013 Dec; 55(4):353-61. PubMed ID: 24434344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons.
    Bonaventura K; Sonntag S; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to use the drug-eluting balloon: recommendations by the German consensus group.
    Kleber FX; Mathey DG; Rittger H; Scheller B;
    EuroIntervention; 2011 May; 7 Suppl K():K125-8. PubMed ID: 22027722
    [No Abstract]   [Full Text] [Related]  

  • 12. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do we really understand pimecrolimus?
    Vorpahl M; Finn AV; Nakano M; Virmani R
    JACC Cardiovasc Interv; 2009 Oct; 2(10):1025-7. PubMed ID: 19850265
    [No Abstract]   [Full Text] [Related]  

  • 14. Nevo stent: a successful stent makeover.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
    [No Abstract]   [Full Text] [Related]  

  • 15. Local drug delivery for treatment of coronary and peripheral artery disease.
    Gertz ZM; Wilensky RL
    Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting arterial wall inflammation around stents in the porcine coronary artery model.
    Wilson GJ
    J Vasc Interv Radiol; 2011 Feb; 22(2):260-1. PubMed ID: 21276920
    [No Abstract]   [Full Text] [Related]  

  • 18. Catheter based local delivery of fluid paclitaxel: the Tübingen experience.
    Herdeg C
    EuroIntervention; 2011 May; 7 Suppl K():K11-6. PubMed ID: 22027719
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study.
    Belkacemi A; Agostoni P; Voskuil M; Stella PR
    EuroIntervention; 2011 May; 7 Suppl K():K66-9. PubMed ID: 22027731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
    Radke PW; Joner M; Joost A; Byrne RA; Hartwig S; Bayer G; Steigerwald K; Wittchow E
    EuroIntervention; 2011 Oct; 7(6):730-7. PubMed ID: 21986331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.